How I treat brain metastases of melanoma

Brain metastases are common in advanced melanoma and cause death in >50% of patients. Until recently, median survival was only ∼4 months. Improved systemic treatment including immune checkpoint inhibitors and combinations of BRAF/MEK inhibitors, however, has significantly improved intracranial tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Eroglu, Z., Topcu, T.O., Yu, H.M., Margolin, K.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589018/
https://www.ncbi.nlm.nih.gov/pubmed/36274439
http://dx.doi.org/10.1016/j.esmoop.2022.100598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589018/
https://www.ncbi.nlm.nih.gov/pubmed/36274439
http://dx.doi.org/10.1016/j.esmoop.2022.100598

Ejemplares similares